Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) — Stella

Recruiting

Back to Early-stage Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Belgium

Institut Jules Bordet, Brussels, Brussels Capital

Key details

Phase

Safety & dosing

Sponsor

Jules Bordet Institute

Collaborators

KU Leuven

Enrollment target

~112 participants

Started

May 2025

Primary completion

April 2027

Age range

18 Years – 70 Years

Sex

Female only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov